Intensity Therapeutics Inc (INTS)
Intensity Therapeutics Granted 180-Day Extension to Regain Compliance with Nasdaqs Minimum Bid Price Requirement
Intensity Therapeutics Granted 180-Day Extension to Regain Compliance with Nasdaqs Minimum Bid Price Requirement
📊 **NEUTRAL** • Medium confidence analysis (70%) • Weak signals • Minimal impact expected **Sentiment:** Neutral (50%) **Content type:** General